| The pharmacology and therapeutic applications of monoclonal antibodies MS Castelli, P McGonigle, PJ Hornby Pharmacology research & perspectives 7 (6), e00535, 2019 | 316 | 2019 |
| Potentiating adoptive cell therapy using synthetic IL-9 receptors A Kalbasi, M Siurala, LL Su, M Tariveranmoshabad, LK Picton, ... Nature 607 (7918), 360-365, 2022 | 74 | 2022 |
| Cancer Chemotherapy, Immunotherapy, and Biotherapy BA Chabner, DL Longo Lippincott Williams & Wilkins, 2024 | 32 | 2024 |
| Off-the-shelf CAR T cells to treat cancer S Castelli, RM Young, CH June Cell Research 32 (12), 1036-1037, 2022 | 17 | 2022 |
| CAR T cell combination therapies to treat cancer U Uslu, S Castelli, CH June Cancer Cell 42 (8), 1319-1325, 2024 | 15 | 2024 |
| Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy A DiNatale, R Kaur, C Qian, J Zhang, M Marchioli, D Ipe, M Castelli, ... Oncogene 41 (9), 1337-1351, 2022 | 15 | 2022 |
| The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion U Uslu, L Sun, S Castelli, AV Finck, CA Assenmacher, RM Young, ... Nature communications 15 (1), 3933, 2024 | 14 | 2024 |
| Considerations for addressing anti‐vaccination campaigns: How did we get here and what can we do about it? JS Barrett, SY Yang, K Muralidharan, V Javes, K Oladuja, MS Castelli, ... Clinical and Translational Science 15 (6), 1380-1386, 2022 | 8 | 2022 |
| Regulation of tumor and metastasis initiation by chemokine receptors A DiNatale, MS Castelli, B Nash, O Meucci, A Fatatis Journal of Cancer 13 (11), 3160, 2022 | 6 | 2022 |
| 316 STING agonist-induced IL-18 secretion enhances CAR T cell function U Uslu, S Castelli, A Finck, CA Assenmacher, L Sun, RM Young, Z Chen, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 238 Potentiating CAR T cell therapy through synthetic IL-9R signaling S Castelli, U Uslu, A Finck, T Da, CA Assenmacher, M Siurala, RM Young, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 256 Dual-targeted CAR T cells boost antitumor immunity against solid tumors A Finck, Z Wang, U Uslu, S Castelli, A Rech, J Latini J Immunother 11 (1), A1-A1731, 2023 | | 2023 |
| Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy J Zhang, A DiNatale, R Kaur, Q Chen, M Marchioli, D Ipe, M Castelli, ... Cancer Research 82 (12_Supplement), 2193-2193, 2022 | | 2022 |
| Regulation of pluripotency genes by CX3CR1 in cancer cells MS Castelli Drexel University, 2020 | | 2020 |
